Envestnet Asset Management Inc Cytokinetics Inc Transaction History

Envestnet Asset Management Inc

$326 Billion
Q2 2025

A detailed history of Envestnet Asset Management Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 29,467 shares of CYTK stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,467

Previous 24,321 21.16%

Holding current value

$1.74 Million

Previous $977,000 0.41%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	BUY	$29.84 - $42.92 $153,556 - $220,866	5,146 Added 21.16%	29,467 $973,000
Q1 2025 Apr 29, 2025	SELL	$40.19 - $51.12 $85,765 - $109,090	-2,134 Reduced 8.07%	24,321 $977,000
Q4 2024 Feb 12, 2025	SELL	$46.36 - $58.62 $306,532 - $387,595	-6,612 Reduced 20.0%	26,455 $1.24 Million
Q3 2024 Nov 06, 2024	BUY	$51.22 - $60.16 $125,028 - $146,850	2,441 Added 7.97%	33,067 $1.75 Million
Q2 2024 Aug 08, 2024	BUY	$47.86 - $75.05 $293,238 - $459,831	6,127 Added 25.01%	30,626 $1.66 Million
Q1 2024 May 13, 2024	BUY	$63.75 - $108.06 $238,552 - $404,360	3,742 Added 18.03%	24,499 $1.72 Million
Q4 2023 Feb 13, 2024	SELL	$26.88 - $83.49 $193,536 - $601,128	-7,200 Reduced 25.75%	20,757 $1.73 Million
Q3 2023 Nov 13, 2023	BUY	$29.46 - $36.61 $207,486 - $257,844	7,043 Added 33.68%	27,957 $823,000
Q2 2023 Aug 04, 2023	SELL	$32.62 - $40.75 $14,026 - $17,522	-430 Reduced 2.01%	20,914 $682,000
Q1 2023 May 11, 2023	BUY	$33.36 - $45.71 $2,401 - $3,291	72 Added 0.34%	21,344 $751,000
Q4 2022 Feb 07, 2023	SELL	$35.77 - $51.11 $85,812 - $122,612	-2,399 Reduced 10.13%	21,272 $974,000
Q3 2022 Nov 10, 2022	SELL	$38.54 - $54.52 $14,067 - $19,899	-365 Reduced 1.52%	23,671 $1.15 Million
Q2 2022 Aug 03, 2022	BUY	$33.93 - $48.92 $142,573 - $205,561	4,202 Added 21.19%	24,036 $944,000
Q1 2022 May 04, 2022	BUY	$29.74 - $46.0 $42,201 - $65,274	1,419 Added 7.71%	19,834 $730,000
Q4 2021 Feb 04, 2022	BUY	$34.35 - $46.38 $91,027 - $122,907	2,650 Added 16.81%	18,415 $839,000
Q3 2021 Oct 07, 2021	SELL	$18.54 - $35.74 $87,360 - $168,406	-4,712 Reduced 23.01%	15,765 $563,000
Q2 2021 Aug 04, 2021	BUY	$19.79 - $26.99 $33,247 - $45,343	1,680 Added 8.94%	20,477 $405,000
Q1 2021 May 04, 2021	BUY	$18.57 - $25.68 $128,133 - $177,192	6,900 Added 58.0%	18,797 $437,000
Q4 2020 Feb 02, 2021	SELL	$15.26 - $28.61 $26,582 - $49,838	-1,742 Reduced 12.77%	11,897 $247,000
Q3 2020 Oct 09, 2020	BUY	$20.58 - $28.96 $18,398 - $25,890	894 Added 7.01%	13,639 $295,000
Q2 2020 Jul 08, 2020	SELL	$11.15 - $24.64 $82,052 - $181,325	-7,359 Reduced 36.6%	12,745 $300,000
Q1 2020 Apr 23, 2020	BUY	$8.75 - $16.3 $175,910 - $327,695	20,104 New	20,104 $237,000

Others Institutions Holding CYTK

# of Institutions

375

Shares Held

129M

Call Options Held

3.62M

Put Options Held

1.14M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $5.55B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Cytokinetics Inc Transaction History